Home/Filings/4/0001213900-23-006044
4//SEC Filing

Fabbio Patrick 4

Accession 0001213900-23-006044

CIK 0001359931other

Filed

Jan 29, 7:00 PM ET

Accepted

Jan 30, 4:52 PM ET

Size

5.7 KB

Accession

0001213900-23-006044

Insider Transaction Report

Form 4
Period: 2023-01-30
Fabbio Patrick
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-01-30+300,000300,000 total
    Exercise: $3.14Exp: 2033-01-29Common Stock (300,000 underlying)
Footnotes (1)
  • [F1]One-fourth of the shares shall vest on January 30, 2024 and the remainder of the shares will vest in a series of thirty-six successive equal monthly installments measured from January 30, 2024, subject to the Reporting Person's Continuous Service (as defined in the Company's 2020 Inducement Plan) with the Issuer through each such vesting date.

Documents

1 file

Issuer

Protara Therapeutics, Inc.

CIK 0001359931

Entity typeother

Related Parties

1
  • filerCIK 0001658859

Filing Metadata

Form type
4
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 4:52 PM ET
Size
5.7 KB